APOE and atherosclerosis: The use of murine models in atherosclerosis was catalyzed by the development of the apolipoprotein E (APOE) knockout mouse by the Breslow (103) and the Maeda (104) laboratories, and the LDL receptor (LDLR) knockout mouse by the Brown and Goldstein laboratory (105) in the early 1990s.